author-photo

Shana Trostel

National Institutes of Health

20

Papers

309

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

A case report of multiple primary prostate tumors with differential drug sensitivity

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (14)
Low abundance of circulating tumor DNA in localized prostate cancer

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (12)
Therapeutic targeting of Ezh2 enhances PD-1 blockade by induction of interferon gamma response

2019
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 736: Development of an allele-specific assay for detecting circulating tumor DNA in prostate cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Molecular and histopathologic correlates of imaging and biological responses to neoadjuvant GnRH agonist plus enzalutamide for high risk prostate cancer.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract LB-275: Precise enumeration of cell-free DNA from patient-derived cell lines

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins

2015 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (107)
Abstract LB-106: Microtubule-targeting agents (MTAs) disrupt intracellular trafficking of DNA repair proteins and augment the toxicity of DNA damaging agents (DDAs)

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)